Management of Node-Positive and Oligometastatic Prostate Cancer.

Semin Radiat Oncol

Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address:

Published: January 2017

AI Article Synopsis

  • Historically, stage IV prostate cancer was viewed as incurable, but some cases may be treatable with aggressive multimodal treatments.
  • Node-positive and oligometastatic prostate cancers are both categorized as stage IV, yet they likely represent different clinical groups with varying outcomes.
  • While randomized evidence is limited, retrospective studies indicate that treatments like radical prostatectomy or radiotherapy could enhance survival, highlighting the need for more research and clinical trials in this area.

Article Abstract

Historically, stage IV prostate cancer was considered incurable. Although node-positive and oligometastatic prostate cancers are both classified as stage IV, these likely represent distinct clinical groups, and some patients may be curable with aggressive multimodality treatments. There is a lack of randomized evidence, but retrospective studies suggest that radical prostatectomy or radiotherapy may improve survival in these patients. This is an area of great current research interest and prospective randomized trials are needed to help define the optimal treatments for these patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2016.08.006DOI Listing

Publication Analysis

Top Keywords

node-positive oligometastatic
8
oligometastatic prostate
8
prostate cancer
8
management node-positive
4
cancer historically
4
historically stage
4
stage prostate
4
cancer considered
4
considered incurable
4
incurable node-positive
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!